Showing results (1081-1090 of 1,156) with videos related to

Sort By:
Pageof 116
Diabetologia|September 10, 2020
Associations of gestational diabetes and type 2 diabetes during pregnancy with breastfeeding at hospital discharge and up to 6 months: the PANDORA studyDanielle K Longmore, Elizabeth L M Barr, Alyce N Wilson, et al.
The British Journal of Surgery|April 16, 2010
Variations in locoregional therapy in postmenopausal patients with early breast cancer treated in different countriesJ G H van Nes, C Seynaeve, S Jones, et al.
The Journal of Infectious Diseases|September 9, 2022
Longitudinal Evaluation of Antibody Persistence in Mother-Infant Dyads After Severe Acute Respiratory Syndrome Coronavirus 2 Infection in PregnancyMary C Cambou, Christine M Liu, Thalia Mok, et al.
Cells|January 16, 2020
Investigating the Potential and Pitfalls of EV-Encapsulated MicroRNAs as Circulating Biomarkers of Breast CancerBrian M Moloney, Katie E Gilligan, Doireann P Joyce, et al.
BJGP Open|May 19, 2021
SARS-CoV-2 infection in general practice in Ireland: a seroprevalence studyMichael E O'Callaghan, Elizabeth Ryan, Cathal Walsh, et al.
Communications Medicine|May 2, 2025
SARS-CoV-2 humoral immune responses in convalescent individuals over 12 months reveal severity-dependent antibody dynamicsNadia Siles Alvarado, Maisey Schuler, Cole Maguire, et al.
BMC Public Health|February 20, 2010
Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR studyLouise J Maple-Brown, Paul D Lawton, Jaquelyne T Hughes, et al.
Breast Cancer Research and Treatment|April 27, 2019
The impact of communication style on patient satisfactionAmelia A Trant, Borbala Szekely, Sarah S Mougalian, et al.
Journal of Diabetes|January 26, 2019
Real-world experience of metformin use in pregnancy: Observational data from the Northern Territory Diabetes in Pregnancy Clinical RegisterLouise J Maple-Brown, Greta Lindenmayer, Federica Barzi, et al.
NPJ Breast Cancer|July 20, 2017
Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trialKerin Adelson, Bhuvaneswari Ramaswamy, Joseph A Sparano, et al.
Pageof 116